Research article
Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial
Arthritis Research & Therapy 2009, 11:R170 doi:10.1186/ar2859
Accesses
- Last 30 days: 219 accesses
- Last 365 days: 1770 accesses
- All time: 6687 accesses

